Intergalactic plans to progress non-viral gene therapy program into the clinic 16-Mar-2023 By Jane Byrne Intergalactic Therapeutics, a startup focused on non-viral gene therapy, reports positive preclinical results for its lead program, IG-002, addressing all forms of ABCA4-related retinopathies.